• Users Online: 39805
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF COMMUNICATION

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children

Kaul Shalini, Uparkar Mahesh, Mody Kruti, Walinjkar Jaydeep, Kothari Mihir, Natarajan S

Year : 2010| Volume: 58| Issue : 1 | Page no: 76-78

   This article has been cited by
 
1 Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Drugs for Coats' Disease Treatment: A Systematic Review
Jie Bai, Zhihui Song, Guangyao Li, Liming Dong, Chao Zhang
Journal of Ocular Pharmacology and Therapeutics. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
Fukutaro Mano, Itsuka Matsushita, Hiroyuki Kondo, Shoko Utamura, Chiori Kondo, Shunji Kusaka
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
3 Three-year follow-up of Coats disease treated with conbercept and 532-nm laser photocoagulation
Li Jiang, Bo Qin, Xiao-Ling Luo, He Cao, Ting-Ming Deng, Ming-Ming Yang, Ting Meng, Hui-Qin Yang
World Journal of Clinical Cases. 2020; 8(24): 6243
[Pubmed]  [Google Scholar] [DOI]
4 Multiple Therapy Approach for Stage 3 Coats Disease: Long-Term Follow-Up
Rodolfo Mastropasqua, Rossella D’Aloisio, Paulo Eduardo Stanga, Richard Haynes, Bartosz Sikorski
Journal of Ophthalmology. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
5 Coats’ disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease
Yacoub A. Yousef, Ahmad H. ElRimawi, Rashed M. Nazzal, Ahmad F. Qaroot, Adnan H. AlAref, Mona Mohammad, Omar Abureesh, Robert Rejdak, Katarzyna Nowomiejska, Teresio Avitabile, Mario Damiano Toro, Ibrahim AlNawaiseh
Medicine. 2020; 99(16): e19623
[Pubmed]  [Google Scholar] [DOI]
6 LONG-TERM ANATOMICAL AND FUNCTIONAL OUTCOMES FOLLOWING VITRECTOMY FOR ADVANCED COATS DISEASE
Murat Karacorlu, Mumin Hocaoglu, Isil Sayman Muslubas, Serra Arf
Retina. 2017; 37(9): 1757
[Pubmed]  [Google Scholar] [DOI]
7 Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease
Qiong Yang, Wenbin Wei, Xuehui Shi, Lihong Yang
Acta Ophthalmologica. 2016; 94(4): 401
[Pubmed]  [Google Scholar] [DOI]
8 The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: Our experience of 975 infants and children
Ashwin Mallipatna, Anand Vinekar, Chaitra Jayadev, Supriya Dabir, Munsusamy Sivakumar, Narasimha Krishnan, Pooja Mehta, Tos Berendschot, NareshKumar Yadav
Indian Journal of Ophthalmology. 2015; 63(7): 586
[Pubmed]  [Google Scholar] [DOI]
9 Intraoperative Fluorescein Angiography–Guided Treatment in Children with Early Coatsæ Disease
Martina Suzani,Anthony T. Moore
Ophthalmology. 2015;
[Pubmed]  [Google Scholar] [DOI]
10 RANIBIZUMAB IN THE MANAGEMENT OF ADVANCED COATS DISEASE STAGES 3B AND 4
Marie-Claire Gaillard,Assimina Mataftsi,Aubin Balmer,Susan Houghton,Francis L. Munier
Retina. 2014; 34(11): 2275
[Pubmed]  [Google Scholar] [DOI]
11 An interesting case of Coatsæ disease
Avinash Mishra,Somesh Aggarwal,Sonali Shah,Puja Negi,Rekha Bharwada,Neha Desai
Medical Journal Armed Forces India. 2014;
[Pubmed]  [Google Scholar] [DOI]
12 Optical Coherence Tomography in Pediatric Ophthalmology: Current Roles and Future Directions
Tarek Alasil,Pearse A. Keane,Dawn A. Sim,Adnan Tufail,Michael E. Rauser
Ophthalmic Surgery, Lasers and Imaging Retina. 2013; 44(6 (Suppl)): S19
[Pubmed]  [Google Scholar] [DOI]
13 Combination Treatment of Pediatric Coats’ Disease: A Bicenter Study in Taiwan
Chun-Ju Lin,San-Ni Chen,Jiunn-Feng Hwang,Chung-May Yang
Journal of Pediatric Ophthalmology & Strabismus. 2013; 50(6): 356
[Pubmed]  [Google Scholar] [DOI]
14 An Evidence-Based Review of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 2. Coats’ Disease, Best Disease, and Uveitis With Childhood Neovascularization
Khurram M. Chaudhary,Mihai Mititelu,Ronni M. Lieberman
Journal of Pediatric Ophthalmology & Strabismus. 2013; 50(1): 11
[Pubmed]  [Google Scholar] [DOI]
15 Current management of Coats disease
Eric J. Sigler,John C. Randolph,Jorge I. Calzada,Matthew W. Wilson,Barrett G. Haik
Survey of Ophthalmology. 2013;
[Pubmed]  [Google Scholar] [DOI]
16 Diagnosis and treatment of coatsæ disease: A review of the literature
Ghorbanian, S., Jaulim, A., Chatziralli, I.P.
Ophthalmologica. 2012; 227(4): 175-182
[Pubmed]  [Google Scholar]
17 Bevacizumab for Coatsæ disease with exudative retinal detachment and risk of vitreoretinal traction
Ramasubramanian, A., Shields, C.L.
British Journal of Ophthalmology. 2012; 96(3): 356-359
[Pubmed]  [Google Scholar]
18 DIFFUSE RETINAL CAPILLARY LEAKAGE IN COATS DISEASE
Ron Margolis,Francisco A. Folgar,Magdy Moussa,Lawrence A. Yannuzzi
Retinal Cases & Brief Reports. 2012; 6(3): 285
[Pubmed]  [Google Scholar] [DOI]
19 Diffuse retinal capillary leakage in Coats disease
Margolis, R., Folgar, F.A., Moussa, M., Yannuzzi, L.A.
Retinal Cases and Brief Reports. 2012; 6(3): 285-289
[Pubmed]  [Google Scholar]
20 Diagnosis and Treatment of Coats? Disease: A Review of the Literature
Samim Ghorbanian,Adil Jaulim,Irini P. Chatziralli
Ophthalmologica. 2012; 227(4): 175
[Pubmed]  [Google Scholar] [DOI]
21 Coats disease and exudative retinopathy
Reichstein, D.A., Recchia, F.M.
International Ophthalmology Clinics. 2011; 51(1): 93-112
[Pubmed]  [Google Scholar]
22 Treatment of Coats disease by laser photocoagulation combined with intravitreal bevacizumab
Fujiya, A., Saito, W., Ishida, S.
Japanese Journal of Clinical Ophthalmology. 2011; 65(6): 869-873
[Pubmed]  [Google Scholar]
23 Other diseases and serous retinal detachment | [Diǧer hastaliklar ve seröz retina dekolmanlari]
Kaderli, B.
Retina-Vitreus. 2011; 19(2): 86-89
[Pubmed]  [Google Scholar]
24 Role of intravitreal bevacizumab in adult onset Coatsæ disease
Goel, N., Kumar, V., Seth, A., Raina, U.K., Ghosh, B.
International Ophthalmology. 2011; 31(3): 183-190
[Pubmed]  [Google Scholar]
25 A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset coatsæ disease
Wang, K.-Y., Cheng, C.-K.
Journal of Ocular Pharmacology and Therapeutics. 2011; 27(5): 525-530
[Pubmed]  [Google Scholar]
26 Role of intravitreal bevacizumab in adult onset Coats’ disease
Neha Goel,Vinod Kumar,Anisha Seth,Usha Kaul Raina,Basudeb Ghosh
International Ophthalmology. 2011; 31(3): 183
[Pubmed]  [Google Scholar] [DOI]
27 A Combination of Intravitreal Bevacizumab Injection with Tunable Argon Yellow Laser Photocoagulation as a Treatment for Adult-Onset Coatsæ Disease
Kai-Yun Wang,Cheng-Kuo Cheng
Journal of Ocular Pharmacology and Therapeutics. 2011; 27(5): 525
[Pubmed]  [Google Scholar] [DOI]
28 Coats Disease and Exudative Retinopathy
David A. Reichstein,Franco M. Recchia
International Ophthalmology Clinics. 2011; 51(1): 93
[Pubmed]  [Google Scholar] [DOI]
29 Elevated vascular endothelial growth factor level in Coatsæ disease and possible therapeutic role of bevacizumab
He, Y.-G., Wang, H., Zhao, B., Lee, J., Bahl, D., McCluskey, J.
Graefeæs Archive for Clinical and Experimental Ophthalmology. 2010; 248(10): 1519-1521
[Pubmed]  [Google Scholar]
30 Anti-VEGF as adjunctive therapy for Coats disease: In this case report, anti-vegf therapy obviated the need for subretinal drainage, improving outcomes
Waite, K., Eugene, N.G., Bennett, M.D.
Retina Today. 2010; : 46-49
[Pubmed]  [Google Scholar]

 

Read this article